Drug Profile
SDZ CPI 975
Alternative Names: CPI 975; SDZ 266975Latest Information Update: 08 Oct 2001
Price :
$50
*
At a glance
- Originator Novartis
- Class Antihyperglycaemics
- Mechanism of Action Carnitine O-palmitoyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus